Maintenance vinflunine post cisplatin chemotherapy (CT) in patients with advanced urothelial carcinoma (UC): Preliminary analysis of a randomized placebo controlled phase II trial (MAJA trial)—SOGUG 2011-02.

Authors

null

Joaquim Bellmunt

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Joaquim Bellmunt , Begona Perez Valderrama , Albert Font , Juan Antonio Virizuela , Miguel Angel Climent , Susana Hernando Polo , Begona Mellado , Nuria Laínez , Aranzazu Gonzalez del Alba , Jose Angel Arranz , Jose Carlos Villa Guzman , Maria del Mar LLorente , Daniel E. Castellano , Enrique Gallardo , Xavier Garcia del Muro , Urbano Anido , Montserrat Domenech , Javier Puente , Jose Luis Perez Gracia , Jesús García-Donas

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT01529411

Citation

J Clin Oncol 33, 2015 (suppl; abstr 4529)

DOI

10.1200/jco.2015.33.15_suppl.4529

Abstract #

4529

Poster Bd #

200

Abstract Disclosures